跳至主要内容
临床试验/ISRCTN44582462
ISRCTN44582462已完成不适用

An open randomised trial to evaluate different therapeutic strategies of combination therapy for human immunodeficiency virus (HIV-1) Infectio

Medical Research Council (UK)0 个研究点目标入组 1,000 人开始时间: 2005年9月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • •The participants in the trial must be HIV-1 infected, over 18 years of age, at any stage of HIV disease, but not acute symptomatic primary infection, where anti-retroviral therapy is indicated. Participants should be likely to take their first regimen for at least 6 months and be expected to adhere to the protocol.

排除标准

  • •1. The participants must not have received prior treatment with antiretroviral drugs or immunotherapy
  • •2. There must be no history of peripheral neuropathy or pancreatitis
  • •3. Individuals must not be receiving combination cytotoxic chemotherapy for cancer or parental therapy for an active opportunistic infection
  • •4. Women should not be pregnant, breastfeeding or unwilling to use adequate contraception
  • •5. Participants will be ineligible if biochemistry and haematology blood results from screening are outside the trial upper safety limits.

研究者

发起方
Medical Research Council (UK)

相似试验